Blonanserin N-oxide is an oxidation derivative of the antipsychotic Blonanserin, featuring an N-oxide functional group at the piperazine nitrogen of the parent compound's dibenzothiazepine core. This structural modification introduces a polar, electron-withdrawing oxygen atom, altering the molecule's physicochemical properties while retaining the thiazepine and aromatic ring systems critical to pharmacological activity. The compound arises as a synthetic byproduct during API manufacturing processes involving oxidative conditions. It serves as a critical impurity reference standard for HPLC-based quality control in Blonanserin formulations.
On RequestCC[N+]1(CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F)[O-]
InChI=1S/C23H30FN3O/c1-2-27(28)15-13-26(14-16-27)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3
OTCKVXVFRUCJOH-UHFFFAOYSA-N